Ghrelink's novel neuroprotective effects in Parkinson's disease are mediated by AMP-activated protein kinase (AMPK)

Project: Research

Status	Finished
Effective start/end date	5/01/09 → 31/12/11

Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1-40) administration in mice
Santos, V. V., Stark, R., Rial, D., Silva, H. B., Bayliss, J. A., Lemus, M. B., Davies, J. S., Cunha, R. A., Prediger, R. D. S. & Andrews, Z. B., 1 May 2017, In: Journal of Neuroendocrinology. 29, 5, 11 p.
Research output: Contribution to journal › Article › Research › peer-review

53 Citations (Scopus)
Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways
Stievenard, A., Mequinion, M., Andrews, Z. B., Destée, A., Chartier-Harlin, M.-C., Viltart, O. & Vanbesien-Mailliot, C. C., Feb 2017, In: Neuroscience and Biobehavioral Reviews. 73, p. 255-275 21 p.
Research output: Contribution to journal › Review Article › Other › peer-review

28 Citations (Scopus)
Acylated but not des-acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's Disease
Bayliss, J. A., Lemus, M. B., Valgas dos Santos, V., Deo, M. H., Elsworth, J. D. & Andrews, Z. B., 2016, In: Journal of Neurochemistry. 137, 3, p. 460 - 471 12 p.
Research output: Contribution to journal › Article › Research › peer-review

47 Citations (Scopus)

Project Details